merck glp 1 agonist GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art Merck seeks GLP-1 drugs with

A positive connectivity score (close to +1) indicates the compound has a gene expression profile similar to that of a specific drug

Kidney360 2 , 254262 (2021)

It comprised adults with T2D who had discontinued an oral glucose-lowering medication or were treatment-nave

520 The anti-tumor effect of liraglutide is related to its inhibition of the PI3K/Akt signaling pathway, as the activation of Akt is crucial for promoting cell survival and proliferation, and liraglutide can inhibit this process in a dose-dependent manner

Patients should contact their healthcare provider if they experience severe abdominal pain, persistent vomiting, signs of pancreatitis, symptoms of gallbladder disease, or symptoms of thyroid tumors (neck mass, difficulty swallowing, persistent hoarseness)

39 Although GLP-1RAs continue to be promising therapies for T2D, their long-term efficacy for weight loss after halting treatment should be further improved